Cardiogenic shock accounts for~ 100,000 annual hospital admissions in the United States.
Despite improvements in medical management strategies, in-hospital mortality remains …

Background Prior research suggests an association between clinical outcomes in heart
failure (HF) and social determinants of health (SDoH). Because providers should identify …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Background There are few studies documenting the changing epidemiology and outcomes
of shock in cardiac intensive care unit (CICU) patients. We sought to describe the changes in …

Epidemiology and causes of cardiogenic shock : Current Opinion in Critical Care
Epidemiology and causes of cardiogenic shock : Current Opinion in Critical Care Log in or …

Aims Published data on cardiogenic shock (CS) are scarce and are mostly focused on small
registries of selected populations. The aim of this study was to examine the current CS …

Anticoagulation of patients treated with the Impella percutaneous mechanical circulatory
support (MCS) devices is complex and lacks consistency across centers, potentially …

Background Cardiogenic shock (CS) is a systemic disorder associated with dismal short-
term prognosis. Given its time-dependent nature, mechanical circulatory support may …

Background There is considerable debate about the hemodynamic effects of veno‐arterial
extracorporeal membrane oxygenation (VA‐ECMO). Aims To evaluate the changes in left …

The intra-aortic balloon pump (IABP) is widely implanted as temporary mechanical
circulatory support for cardiogenic shock (CS). However, its use is declining following the …